Re: @ wolfetone
The NHS will always need more because it's a victim of its own success. Every life it prolongs now becomes a future patient needing treatment for the degenerative diseases of old age. So what is the solution, is there one?
Do we assess a treatment not only on its cost and effectiveness, but also on its utility? A costly, but life-saving treatment could be considered "worth it" for a thirty-something, but not for a sixty-something, based on tax contributions they are likely to make. It's the thin end of a rather nasty wedge; what other variables do you factor in? Do you prioritise treatment based on income, as that will offer a higher "return"? Speaking as someone who has spent most of his adult life taking medication, which has allowed me to be a well-paid, productive member of society, I don't like the idea of a system that might prioritise my treatment while I'm working, but when I hit retirement, no longer deems me worth it.